Variant report

Variant	esv3421979
Chromosome Location	chr6:35478924-35481222
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:14)
CpG islands
(count:611)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:14 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:35480648-35480774	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr6:35480720-35480870	WERI-Rb-1	eye:	n/a	n/a
3	EGR1	chr6:35479248-35479537	K562	blood:	n/a	chr6:35479386-35479401 chr6:35479387-35479400 chr6:35479387-35479400 chr6:35479387-35479400
4	EGR1	chr6:35479257-35479486	K562	blood:	n/a	chr6:35479386-35479401 chr6:35479387-35479400 chr6:35479387-35479400 chr6:35479387-35479400
5	ELF1	chr6:35479851-35480062	K562	blood:	n/a	n/a
6	POLR2A	chr6:35479529-35479589	H1-hESC	embryonic stem cell:	n/a	n/a
7	RXRA	chr6:35479902-35480215	H1-hESC	embryonic stem cell:	n/a	chr6:35480059-35480075
8	SIN3A	chr6:35479944-35480041	H1-hESC	embryonic stem cell:	n/a	n/a
9	SIN3A	chr6:35479395-35479401	H1-hESC	embryonic stem cell:	n/a	n/a
10	STAT3	chr6:35478934-35478939	MCF10A-Er-Src	breast:	n/a	n/a
11	ZBTB7A	chr6:35479847-35480114	K562	blood:	n/a	n/a
12	ZBTB7A	chr6:35479840-35480341	K562	blood:	n/a	n/a
13	ZBTB7A	chr6:35480644-35480815	K562	blood:	n/a	n/a
14	ZBTB7A	chr6:35480253-35480431	K562	blood:	n/a	n/a

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:35480129-35480179	MCF10A-Er-Src	breast:	n/a
2	chr6:35480129-35480179	MCF10A-Er-Src	breast:	n/a
3	chr6:35480036-35480086	AoSMC	blood vessel:	n/a
4	chr6:35480426-35480476	HAEpiC	amniotic membrane:	n/a
5	chr6:35479910-35479960	GM12878	blood:	n/a
6	chr6:35480129-35480179	HNPCEpiC	eye:	n/a
7	chr6:35479350-35479400	LNCaP	prostate:	n/a
8	chr6:35480916-35480966	NHDF-neo	bronchial:	n/a
9	chr6:35480779-35480829	BE2_C	brain:	n/a
10	chr6:35480625-35480675	GM12878	blood:	n/a
11	chr6:35479648-35479698	SKMC	muscle:	n/a
12	chr6:35479910-35479960	HepG2	liver:	n/a
13	chr6:35480916-35480966	IMR90	lung:	fetal
14	chr6:35480779-35480829	GM12892	blood:	n/a
15	chr6:35480129-35480179	ovcar-3	ovarian:	n/a
16	chr6:35480426-35480476	SAEC	small airway:	n/a
17	chr6:35479648-35479698	HepG2	liver:	n/a
18	chr6:35479628-35479678	AG09319	gingival:	n/a
19	chr6:35479628-35479678	NHBE	bronchial:	n/a
20	chr6:35480036-35480086	PFSK-1	brain:	n/a
21	chr6:35480426-35480476	HEEpiC	esophagus:	n/a
22	chr6:35479648-35479698	NHBE	bronchial:	n/a
23	chr6:35479910-35479960	AoSMC	blood vessel:	n/a
24	chr6:35480916-35480966	SAEC	small airway:	n/a
25	chr6:35480916-35480966	NHBE	bronchial:	n/a
26	chr6:35479628-35479678	RPTEC	kidney:	n/a
27	chr6:35479628-35479678	MCF-7	breast:	n/a
28	chr6:35479350-35479400	K562	blood:	n/a
29	chr6:35480129-35480179	HRPEpiC	eye:	n/a
30	chr6:35480426-35480476	Caco-2	colon:	n/a
31	chr6:35480036-35480086	AG09309	skin:	n/a
32	chr6:35480036-35480086	HCPEpiC	choroid plexus:	n/a
33	chr6:35480625-35480675	IMR90	lung:	fetal
34	chr6:35480625-35480675	GM19239	blood:	n/a
35	chr6:35479910-35479960	ProgFib	skin:	n/a
36	chr6:35480036-35480086	HIPEpiC	eye:	n/a
37	chr6:35479648-35479698	GM12892	blood:	n/a
38	chr6:35479350-35479400	A549	lung:	n/a
39	chr6:35480916-35480966	ovcar-3	ovarian:	n/a
40	chr6:35480129-35480179	GM19239	blood:	n/a
41	chr6:35479628-35479678	PrEC	prostate:	n/a
42	chr6:35480625-35480675	SK-N-MC	brain:	n/a
43	chr6:35480625-35480675	GM12891	blood:	n/a
44	chr6:35480129-35480179	SK-N-SH_RA	brain:	n/a
45	chr6:35480426-35480476	SK-N-SH	brain:	n/a
46	chr6:35480625-35480675	HAEpiC	amniotic membrane:	n/a
47	chr6:35480129-35480179	CMK	blood:	n/a
48	chr6:35479910-35479960	AG09319	gingival:	n/a
49	chr6:35480036-35480086	PrEC	prostate:	n/a
50	chr6:35479350-35479400	HCT-116	colon:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:35476971..35479724-chr6:35699932..35701695,3	MCF-7	breast:
2	chr6:35474441..35476713-chr6:35477709..35479563,2	K562	blood:

No data

Variant related genes	Relation type
TULP1	TF binding region
TULP1	CpG island

Extended variants
information (count: 97 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:97 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs552283926	chr6:35478974-35478975	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs182867001	chr6:35479064-35479065	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs189094210	chr6:35479079-35479080	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs114333667	chr6:35479110-35479111	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs73746446	chr6:35479115-35479116	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs568218135	chr6:35479173-35479174	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs535781533	chr6:35479357-35479358	Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs556979411	chr6:35479443-35479444	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs568898016	chr6:35479447-35479448	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs150453963	chr6:35479452-35479453	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs372688319	chr6:35479459-35479460	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs145518705	chr6:35479478-35479479	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs554200612	chr6:35479509-35479510	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs377105125	chr6:35479525-35479526	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs200713417	chr6:35479554-35479555	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs557850858	chr6:35479555-35479556	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs7764472	chr6:35479574-35479575	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs541216107	chr6:35479598-35479599	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs73415643	chr6:35479625-35479626	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs575026531	chr6:35479633-35479634	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs542153225	chr6:35479674-35479675	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs563323647	chr6:35479683-35479684	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
23	rs191847245	chr6:35479713-35479714	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
24	rs7746544	chr6:35479763-35479764	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs545809489	chr6:35479874-35479875	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs2273003	chr6:35479876-35479877	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs368716262	chr6:35479886-35479887	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs373819607	chr6:35479889-35479890	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs528589736	chr6:35479910-35479911	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs563158279	chr6:35479937-35479938	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs568280769	chr6:35479939-35479940	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs529180227	chr6:35479951-35479952	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs550864319	chr6:35479992-35479993	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs200344441	chr6:35480010-35480011	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs569188713	chr6:35480074-35480075	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs539397347	chr6:35480142-35480143	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs528758725	chr6:35480154-35480155	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs377482548	chr6:35480168-35480169	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs370910518	chr6:35480226-35480227	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs566439645	chr6:35480227-35480228	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs533931484	chr6:35480261-35480262	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs1540910	chr6:35480262-35480263	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs575007358	chr6:35480267-35480268	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs542041361	chr6:35480333-35480334	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs557199350	chr6:35480337-35480338	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs373260465	chr6:35480338-35480339	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs182947980	chr6:35480347-35480348	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs200197646	chr6:35480392-35480393	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs144077749	chr6:35480398-35480399	Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs281865166	chr6:35480415-35480416	Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	17440070	CNVD

Chromatin state (count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:35466400-35479200	Weak transcription	Right Ventricle	heart
2	chr6:35466800-35479400	Weak transcription	Right Atrium	heart
3	chr6:35473400-35479400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr6:35476800-35479000	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr6:35477000-35479000	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr6:35477400-35480200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr6:35477800-35479200	Bivalent Enhancer	Fetal Muscle Leg	muscle
8	chr6:35478200-35479400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
9	chr6:35478400-35479400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr6:35478400-35479800	Enhancers	Fetal Heart	heart
11	chr6:35478400-35480000	Weak transcription	Spleen	Spleen
12	chr6:35478600-35479000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
13	chr6:35478600-35479000	Enhancers	Fetal Kidney	kidney
14	chr6:35478600-35479000	Enhancers	Fetal Lung	lung
15	chr6:35478600-35479200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr6:35478600-35479200	Bivalent Enhancer	Fetal Stomach	stomach
17	chr6:35478600-35479400	Enhancers	Breast Myoepithelial Primary Cells	Breast
18	chr6:35478600-35479600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
19	chr6:35478600-35480800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr6:35478800-35479000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
21	chr6:35478800-35479000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
22	chr6:35478800-35479000	Enhancers	Primary hematopoietic stem cells	blood
23	chr6:35478800-35479000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr6:35478800-35479000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr6:35478800-35479200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
26	chr6:35478800-35479400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
27	chr6:35478800-35479400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr6:35478800-35479400	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr6:35478800-35479600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr6:35478800-35480200	Enhancers	Placenta Amnion	Placenta Amnion
31	chr6:35478800-35480400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr6:35478800-35480800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr6:35479000-35479200	Enhancers	H9 Cell Line	embryonic stem cell
34	chr6:35479000-35479200	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
35	chr6:35479000-35479200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
36	chr6:35479000-35479200	Bivalent Enhancer	Colon Smooth Muscle	Colon
37	chr6:35479000-35479200	Flanking Active TSS	Fetal Kidney	kidney
38	chr6:35479000-35479200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
39	chr6:35479000-35479200	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
40	chr6:35479000-35479400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
41	chr6:35479000-35479400	Enhancers	HUES48 Cell Line	embryonic stem cell
42	chr6:35479000-35479400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
43	chr6:35479000-35479400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
44	chr6:35479000-35479400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr6:35479000-35479400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr6:35479000-35479400	Bivalent Enhancer	Colonic Mucosa	Colon
47	chr6:35479000-35479400	Bivalent Enhancer	Fetal Intestine Large	intestine
48	chr6:35479000-35479400	Flanking Active TSS	Fetal Lung	lung
49	chr6:35479000-35479400	Enhancers	Ovary	ovary
50	chr6:35479000-35479600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links